Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 3, 2020
Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
AIDS Research and Human Retroviruses
|
June 1, 2019
A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV
Ross D Cranston, Charlene S Dezzutti, Aaron Siegel, et al.
Plos Pathogens
|
August 14, 2015
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission
Martina Kovarova, Olivia D Council, Abhijit A Date, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Science (New York, N.Y.)
|
December 14, 2004
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
Koen Andries, Peter Verhasselt, Jerome Guillemont, et al.
Alimentary Pharmacology & Therapeutics
|
June 2, 2020
Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis
Lucia Macken, Stephen Bremner, Heather Gage, et al.
Oncotarget
|
March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1
Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
British Journal of Clinical Pharmacology
|
November 13, 2021
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor
Jack A Brown, Joanne Bal, Monica Simeoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
Annie Ogasawara, James R Kiefer, Herman Gill, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)
Paul A J Janssen, Paul J Lewi, Eddy Arnold, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Biorxiv : the Preprint Server for Biology
|
November 3, 2020
Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
AIDS Research and Human Retroviruses
|
June 1, 2019
A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV
Ross D Cranston, Charlene S Dezzutti, Aaron Siegel, et al.
Plos Pathogens
|
August 14, 2015
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission
Martina Kovarova, Olivia D Council, Abhijit A Date, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Science (New York, N.Y.)
|
December 14, 2004
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
Koen Andries, Peter Verhasselt, Jerome Guillemont, et al.
Alimentary Pharmacology & Therapeutics
|
June 2, 2020
Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis
Lucia Macken, Stephen Bremner, Heather Gage, et al.
Oncotarget
|
March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1
Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
British Journal of Clinical Pharmacology
|
November 13, 2021
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor
Jack A Brown, Joanne Bal, Monica Simeoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
Annie Ogasawara, James R Kiefer, Herman Gill, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)
Paul A J Janssen, Paul J Lewi, Eddy Arnold, et al.
Page
of 21